Viewing Study NCT07388758


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 2:04 PM
Study NCT ID: NCT07388758
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-05
First Post: 2026-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module